Ollé-Goig J E, Canela-Soler J
Am J Public Health. 1987 Mar;77(3):335-8. doi: 10.2105/ajph.77.3.335.
An outbreak of acute brucellosis infection was detected among the employees of a biologicals manufacturing laboratory located in Girona, Spain. The first cases appeared six weeks after a vaccine with attenuated Brucella melitensis, Rev-1 had been produced for one week. A clinical and epidemiologic investigation conducted among the 164 employees found 22 patients with clinical symptoms and positive serology, and six patients detected by serology only (attack rate: 17.1 per cent). Blood cultures were obtained from two patients and Brucella melitensis was isolated. Employees working in areas with open windows above the laboratory air extracting system had an attack rate of 39.5 per cent, substantially higher than those working in other locations. When vaccine was manufactured again, an electric oven reaching 300 degrees C had been installed in the air extracting system just before its exit to the exterior. Appropriate culture medium plates were exposed to the laboratory air before and after passing through the oven. Brucellae were isolated from the plates exposed to the air before passing through the oven but not after doing so.
在西班牙赫罗纳的一家生物制品制造实验室的员工中检测到急性布鲁氏菌病感染疫情。首例病例出现在用减毒马尔他布鲁氏菌Rev-1生产疫苗一周后的六周。对164名员工进行的临床和流行病学调查发现,22例有临床症状且血清学呈阳性,6例仅通过血清学检测发现(发病率:17.1%)。从两名患者身上采集血培养样本,分离出马尔他布鲁氏菌。在实验室空气抽取系统上方有开窗区域工作的员工发病率为39.5%,大大高于在其他地点工作的员工。再次生产疫苗时,在空气抽取系统出口到室外之前,安装了一个可达300摄氏度的电烤箱。在通过烤箱前后,将合适的培养基平板暴露于实验室空气中。在通过烤箱之前暴露于空气中的平板上分离出了布鲁氏菌,但之后没有分离出。